489 related articles for article (PubMed ID: 18426686)
1. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
Lei Q; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
[TBL] [Abstract][Full Text] [Related]
2. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
Francis JL
Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
[TBL] [Abstract][Full Text] [Related]
3. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
4. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia.
Gerotziafas GT; Elalamy I; Lecrubier C; Lebrazi J; Mirshahi M; Potevin F; Lecompte T; Samama MM
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):511-20. PubMed ID: 11685038
[TBL] [Abstract][Full Text] [Related]
5. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
Newman PM; Chong BH
Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
Newman PM; Chong BH
Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
12. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
[TBL] [Abstract][Full Text] [Related]
13. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.
Chong BH; Eisbacher M
Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
[TBL] [Abstract][Full Text] [Related]
16. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Matsuo T; Wanaka K; Asada R
Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia.
Greinacher A; Fürll B; Selleng S
Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
20. Performance of a new, rapid, automated immunoassay for the detection of anti-platelet factor 4/heparin complex antibodies.
Davidson SJ; Ortel TL; Smith LJ
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):340-4. PubMed ID: 21415710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
